Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Current Deferred Revenue (2017 - 2026)

Neuronetics has reported Current Deferred Revenue over the past 10 years, most recently at $833000.0 for Q1 2026.

  • Quarterly Current Deferred Revenue rose 6.11% to $833000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $833000.0 through Mar 2026, up 6.11% year-over-year, with the annual reading at $753000.0 for FY2025, 22.69% down from the prior year.
  • Current Deferred Revenue was $833000.0 for Q1 2026 at Neuronetics, up from $753000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $2.0 million in Q4 2022 and troughed at $753000.0 in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $1.6 million (2023), against an average of $1.4 million.
  • Year-over-year, Current Deferred Revenue crashed 51.63% in 2025 and then rose 6.11% in 2026.
  • A 5-year view of Current Deferred Revenue shows it stood at $2.0 million in 2022, then fell by 18.18% to $1.6 million in 2023, then plummeted by 39.88% to $974000.0 in 2024, then decreased by 22.69% to $753000.0 in 2025, then grew by 10.62% to $833000.0 in 2026.
  • Per Business Quant, the three most recent readings for STIM's Current Deferred Revenue are $833000.0 (Q1 2026), $753000.0 (Q4 2025), and $754000.0 (Q3 2025).